Gabe Hoffman’s Accipiter Capital Scores Big With Orchid Cellmark Investment

Accipiter Capital is an activist hedge fund founded by Gabe Hoffman in 2002. Prior to starting Accipiter, Hoffman worked at Welch Capital Partners covering healthcare stocks. The most distinctive characteristic of Accipiter is that it is an activist hedge fund like Bill Ackman’s Pershing Square. We like activist hedge funds because activist investing requires additional skills and when done right yields much higher returns. It is also easier to imitate activist investors because they have to report their large activist investments within 10 days. The downside of imitating activist investors is that there are several other people doing the same thing and this may push prices higher as soon as an 13D form is filed.

Bill Ackman in front of Perishi

Last year on March 10th Accipiter filed a 13D firm disclosing that it owns 13.09% of Orchid Cellmark’s (ORCH) outstanding shares. ORCH’s average stock price during the 10 days prior to this filing was around $1.45. The stock price closed at $1.59 on March 10th. So, investors who imitated Accipiter had to pay at least a 10% premium over the prevailing price before the filing. The critical question is this: Does it still make sense to pay a 10% premium to imitate Accipiter?

If you are a small investor and have instant access to 13D filings, you could have initiated a small position in ORCH on March 10th. If you were slow or had to deplow $100K or more, the premium you had to pay would actually be around 20%. ORCH closed at $1.76 on March 11th, 2010. By the end of April ORCH’s stock price reached $2 per share. However, nothing significant really happened here and the stock price went down to $1.35 by the end of August as recession expectations peaked in the market. By the end of November, ORCH reached $1.60. Investors who were able to buy this stock on March 10th didn’t make anything in 8 months. Investors who bought it on March 11th were still under water at the end of November.

However, the stock prices started to climb in December and reached $2 by the end of 2010. Then it stayed there until April 5th. On April 6th LabCorp (LH) announced that it will buy ORCH for $2.80 in cash tender offer.

On Friday Accipiter filed an amendment to its original 13D filing. It stated that it tendered all of its 3.9 Million ORCH shares. This means Accipiter made nearly 95% from its ORCH investment in 15 months. Investors who imitated Accipiter immediately made 75% if they were patient enough.

We didn’t cherry pick this example to show that imitating hedge funds could yield high returns. We will cover other activist investments, so you can drive your own conclusions.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!